Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-1990 | 03-1990 | 12-1989 | 09-1989 | 06-1989 | |
Cash Flows From Operating Activities | |||||
Net Income | N/A | N/A | 939,500 | N/A | N/A |
Depreciation Amortization | N/A | N/A | 229,300 | N/A | N/A |
Other Working Capital | N/A | N/A | -158,000 | N/A | N/A |
Other Operating Activity | 0 | 0 | 21,800 | 0 | 0 |
Operating Cash Flow | $N/A | $N/A | $1,032,600 | $N/A | $N/A |
Cash Flows From Investing Activities | |||||
PPE Investments | N/A | N/A | -554,500 | N/A | N/A |
Net Acquisitions | N/A | N/A | -30,100 | N/A | N/A |
Other Investing Activity | 0 | 0 | -240,200 | 0 | 0 |
Investing Cash Flow | $N/A | $N/A | $-824,800 | $N/A | $N/A |
Cash Flows From Financing Activities | |||||
Dividend Paid | N/A | N/A | -372,000 | N/A | N/A |
Other Financing Activity | 0 | 0 | -165,000 | 0 | 0 |
Financing Cash Flow | $N/A | $N/A | $-537,000 | $N/A | $N/A |
Exchange Rate Effect | N/A | N/A | -9,000 | N/A | N/A |
Beginning Cash Position | N/A | N/A | 661,200 | N/A | N/A |
End Cash Position | N/A | N/A | 323,000 | N/A | N/A |
Net Cash Flow | $N/A | $N/A | $-338,200 | $N/A | $N/A |
Free Cash Flow | |||||
Operating Cash Flow | N/A | N/A | 1,032,600 | N/A | N/A |
Free Cash Flow | 0 | 0 | 1,032,600 | 0 | 0 |